SCHEMBL7676180

SCHEMBL7676180

CCOC(=O)c1nnc(-c2cccnc2)n1-c1c(Cl)c(Cl)cc2nc(OC)c(OC)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
HTT P42858 3/20 0.39
ALDH1A1 P00352 5/20 0.39
TSHR P16473 2/20 0.39
GAA P10253 1/20 0.39
DCTPP1 Q9H773 1/20 0.39
POLB P06746 2/20 0.38
LMNA P02545 2/20 0.38
MMP2 P08253 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
USP2 O75604 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 4/20 0.38
PDE2A O00408 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
APLNR P35414 1/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682502 0.91 PDE2A (0.43) HTTALDH1A1TSHRPOLBLMNA
SCHEMBL27410461 0.90 ACHE (0.41) ACHEHTTALDH1A1TSHRGAA
SCHEMBL7683018 0.83 POLB (0.40) HTTALDH1A1GAAPOLBPDE2A
SCHEMBL7681550 0.83 APLNR (0.41) HTTALDH1A1MAPK1APLNRMEN1
SCHEMBL6678132 0.82 OXTR (0.41) HTTALDH1A1TSHRMAPK1APLNR
SCHEMBL27434412 0.80 PDE2A (0.44) HTTALDH1A1POLBLMNAMAPK1
SCHEMBL7673869 0.79 ALDH1A1 (0.43) HTTALDH1A1TSHRGAAPOLB
SCHEMBL7674184 0.77 SLC2A1 (0.37) HTTALDH1A1TSHRPOLBLMNA
SCHEMBL7673152 0.76 CYP11B2 (0.38) ALDH1A1PDE2AAPLNRNPC1RAB9A
SCHEMBL7676400 0.75 OXTR (0.41) HTTALDH1A1TSHRMAPK1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed